Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLymphomaTeam Member asked a question 💭
Landrum, SC
February 20, 2025
 · 
Be the first to react
A MyLymphomaTeam Member

I'm 2yrs out from an anonymous stem cell that I had 7 months after the CART all is good. I had Folicular triple hit to start then Large diffused Bcell

February 26, 2025
A MyLymphomaTeam Member

That’s great news. 😊. I read your story and updates and you’re a true inspiration. My husband has diffuse large cell B lymphoma. He was treated with RCHOP in May 2023 and we just found out he’s relapsed. So we’re looking at either stem cell or CAR-T next.

February 26, 2025
A MyLymphomaTeam Member

I’m sorry it failed for you, John. 😢. What type of lymphoma do you have, and how are you treating it now?

February 26, 2025
A MyLymphomaTeam Member

I had a CART 3yrs ago it worked great for 90 days then failed. But the lessons I learned were to take the supporting meds they give you to counteract the negative side effects. I was part of the drug study for it made a huge difference. I was able to go home in a week . Those without the drugs were still there for over a month big difference

February 26, 2025
MyLymphomaTeam

CAR-T cell therapy is an innovative treatment for lymphoma that uses a person's own T cells, a type of white blood cell, to fight cancer. The process involves:

1. T Cell Collection: T cells are removed from the patient's blood
2. Genetic Modification: These cells are engineered in a lab to produce chimeric antigen Show Full Answer

CAR-T cell therapy is an innovative treatment for lymphoma that uses a person's own T cells, a type of white blood cell, to fight cancer. The process involves:

1. T Cell Collection: T cells are removed from the patient's blood.
2. Genetic Modification: These cells are engineered in a lab to produce chimeric antigen receptors (CARs) that target cancer cells.
3. Reinfusion: The modified T cells are returned to the patient to attack the lymphoma.

CAR-T therapy is approved for various types of lymphoma, including mantle cell lymphoma (Tecartus), diffuse large B-cell lymphoma (Yescarta, Kymriah), and follicular lymphoma. While it shows promising results, it can have serious side effects like cytokine release syndrome and neurological issues.

February 20, 2025

Related Questions

View All
A MyLymphomaTeam Member asked a question 💭
Napa, CA

A MyLymphomaTeam Member asked a question 💭
Melville, NY

A MyLymphomaTeam Member asked a question 💭
Cleveland, OH